Compounds, methods and formulations for the oral delivery of...

Details Compounds, methods and formulations for the oral delivery of... Compounds, methods and formulations for the oral delivery of...

2011-05-24

2011-05-24

Chandrakumar, Nizal S (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S001000, C549S059000

Reexamination Certificate

active

07947841

ABSTRACT:
The present application relates to novel compounds, methods and formulations useful for the oral delivery of a glucagon like peptide-1 compound or a melanocortin 4 receptor agonist peptide.

REFERENCES:
patent: 2423709 (1947-07-01), Knott
patent: 3578671 (1971-05-01), Wyeth et al.
patent: 4239754 (1980-12-01), Sache et al.
patent: 4925673 (1990-05-01), Steiner et al.
patent: 5273989 (1993-12-01), Schwab et al.
patent: 5541155 (1996-07-01), Leone-Bay et al.
patent: 5643957 (1997-07-01), Leone-Bay et al.
patent: 5650386 (1997-07-01), Leone-Bay et al.
patent: 5693338 (1997-12-01), Milstein
patent: 5820881 (1998-10-01), Milstein
patent: 5866536 (1999-02-01), Leone-Bay et al.
patent: 5955503 (1999-09-01), Leone-Bay et al.
patent: 5965121 (1999-10-01), Leone-Bay et al.
patent: 5976569 (1999-11-01), Milstein
patent: 5989539 (1999-11-01), Leone-Bay et al.
patent: 6001347 (1999-12-01), Leone-Bay et al.
patent: 6071510 (2000-06-01), Leone-Bay et al.
patent: 6100298 (2000-08-01), Leone-Bay et al.
patent: 6211215 (2001-04-01), Momose et al.
patent: 6242495 (2001-06-01), Leone-Bay et al.
patent: 6294580 (2001-09-01), Willson et al.
patent: 6605629 (2003-08-01), Momose et al.
patent: 6903085 (2005-06-01), Thom et al.
patent: 6924284 (2005-08-01), Beaton et al.
patent: 6930120 (2005-08-01), Brooks et al.
patent: 6982278 (2006-01-01), Brooks et al.
patent: 7022725 (2006-04-01), Momose et al.
patent: 7351728 (2008-04-01), Brooks et al.
patent: 2004/0048908 (2004-03-01), Momose et al.
patent: 2004/0077557 (2004-04-01), Ali et al.
patent: 2006/0148858 (2006-07-01), Maekawa et al.
patent: 1129393 (1968-10-01), None
patent: 2373186 (2002-09-01), None
patent: 1160571 (1980-04-01), None
patent: 4234857 (1992-08-01), None
patent: 2002212171 (2002-07-01), None
patent: 2003507456 (2003-02-01), None
patent: 2004277397 (2004-10-01), None
patent: WO 03057215 (1998-01-01), None
patent: WO 9803505 (1998-01-01), None
patent: WO 00/40203 (2000-07-01), None
patent: WO 00/47188 (2000-08-01), None
patent: WO 00/50386 (2000-08-01), None
patent: WO 00/59863 (2000-10-01), None
patent: WO 01/32130 (2001-05-01), None
patent: WO 01/44199 (2001-06-01), None
patent: WO 01/51454 (2001-07-01), None
patent: WO 02/02509 (2002-01-01), None
patent: WO 02/050091 (2002-06-01), None
patent: WO-02064607 (2002-08-01), None
patent: WO 02096359 (2002-12-01), None
patent: WO-02096359 (2002-12-01), None
patent: WO-03015785 (2003-02-01), None
patent: WO-03057215 (2003-07-01), None
patent: WO 03/072195 (2003-09-01), None
patent: WO 2005/000339 (2005-01-01), None
Lakhvich et al. STN Document No. 122:105728, Abstract of Mendeleev Communications (1994), (6), 227-8.
Dai, Y. et al. “A Novel Series of Histone Deacetylase Inhibitors Incorporating Hetero Aromatic Ring Systems as Connection Units.” Science Direct, Bioorganic and Medicinal Chemistry Letters 13, pp. 3817-3820, 2003.
Patel, H. et al. “Oral Administration of Insulin by Encapsulation Within Liposomes.” Febs Letters, vol. 62, No. 1, pp. 60-63, 1976.
Hashimoto, A. et al. Effects of Oral Administration of Positively Charged Insulin Liposomes on Alloxan Diabetic Rats: Preliminary Study. Endocrinology Japan, vol. 26, No. 3, pp. 337-344, 1979.
International Search Report and Written Opinion of International Application No. PCT/US2004/024387,filed Aug. 18, 2004, mailed on Dec. 12, 2004.
Moriya et al. Journal of Medicinal Chemistry (1988), 31 (6), 1197-1204.
Janda et al. STN Accession No: 2002-29404; Document No. 136:340636; Abstract of Heterocyclic Communications (2001) 7 (5), 411-416.
Acta Chemica Scandinavica, (1972), 26(2), p. 541-8.
J. Med. Chem., (1970), 13(4), p. 725-9.

Affiliated with

Also associated with

Rating

Compounds, methods and formulations for the oral delivery of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds, methods and formulations for the oral delivery of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds, methods and formulations for the oral delivery of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2662555